What is it about?
@ERSpublications. This study delineates poorly understood risk factors that are clinically relevant for COPD patients, and quantifies risks pre- and post-vaccination, with implications for informing clinical evaluation, and improving treatment and prevention efforts
Featured Image
Read the Original
This page is a summary of: Pre- and post-vaccination characteristics and risk factors for COVID-19 outcomes in a Swedish population-based cohort of COPD patients, ERJ Open Research, May 2023, European Respiratory Society (ERS),
DOI: 10.1183/23120541.00711-2022.
You can read the full text:
Contributors
The following have contributed to this page
